🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

Michael Saylor's MicroStrategy Nets Over $2B Profit As Bitcoin Rallies Near $42K

Published 05/12/2023, 04:35
Updated 05/12/2023, 05:40
© Reuters.  Michael Saylor's MicroStrategy Nets Over $2B Profit As Bitcoin Rallies Near $42K
MSTR
-
BTC/USD
-

Benzinga - MicroStrategy Inc. (NASDAQ:MSTR) has recorded a profit exceeding $2 billion from its Bitcoin (CRYPTO: BTC) holdings as the cryptocurrency’s price surges past $42,000.

What Happened: MicroStrategy’s substantial Bitcoin investment has generated a significant return. Under the direction of Executive Chairman Michael Saylor, the business intelligence firm began its Bitcoin investment journey in August 2020.

As of November 30, MicroStrategy owned 174,530 Bitcoins, acquired for approximately $5.28 billion at an average cost of $30,252 per Bitcoin.

As Bitcoin’s price soared to $42,000 on Monday, the value of MicroStrategy’s holdings skyrocketed to roughly $7.3 billion, translating to a profit north of $2 billion. Despite a slight pullback to $41,700, the firm’s profit remains substantial.

See Also: Crypto Market Braces For Dramatic Shift: Analyst’s Predictions About Solana, Chainlink, Avalanche Send Sh

Bitcoin had not seen such heights since April 2022, preceding the collapse of the Terra ecosystem. In the 2022 bear market, Bitcoin’s value plummeted below $16,000, posing a significant threat to MicroStrategy’s investment. Nevertheless, Saylor persisted in growing the company’s Bitcoin portfolio, leveraging a mix of debt and equity to fund the purchases.

On Monday, MicroStrategy’s shares experienced a 6% uptick in trading.

Why It Matters: MicroStrategy added 16,130 Bitcoins to its treasury. This move drew praise from billionaire investor and Galaxy Digital CEO Mike Novogratz, who lauded Saylor as a “legend.”

Read Next: Bitcoin Bulls Charge: Analyst Predicts These Peaks For BTC, Ether In 2025

Disclaimer: This content was partially produced with the help of Benzinga Neuro and was reviewed and published by Benzinga editors.

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.